Evexia Lifecare Ltd

📊 Evexia Lifecare Ltd. Reports FY2026 Results with Auditor Qualifications

• Audited standalone and consolidated results for the year ended March 31, 2026, were approved on May 09, 2026.

• Auditor’s report is qualified due to concerns over recoverability of loans receivable (₹735.13 lakhs) and trade receivables (₹2,943.89 lakhs), with no assessment for expected credit loss made by management.

• Investments in unquoted equity shares worth ₹87.39 lakhs lack fair valuation determination.

• Subsidiary Kavit Edible Oil Limited suspended operations since March 2015, with negative net worth and exposure of ₹127.70 lakhs, raising going concern doubts.

• Material misstatements noted in financial instruments, investments, provisions, and documentation; some transactions unverified due to insufficient audit evidence.

• Consolidated results include unaudited financials of six subsidiaries, with total assets of ₹71,543.13 lakhs and revenue of ₹481.03 lakhs for the year.

• Standalone net profit for the year ended March 31, 2026, was ₹153.10 lakhs, compared to ₹130.38 lakhs in the previous year.

• Consolidated net profit for the year ended March 31, 2026, was ₹181.13 lakhs, compared to ₹41.38 lakhs in the previous year.

• Cash flow from operating activities was negative at ₹(2,288.06) lakhs (standalone) and ₹(2,348.34) lakhs (consolidated) for the year.